These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7528087)

  • 1. FK506 and deoxyspergualin: experimental studies and clinical applications.
    Suzuki S
    Transpl Immunol; 1994 Sep; 2(3):190-8. PubMed ID: 7528087
    [No Abstract]   [Full Text] [Related]  

  • 2. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of 15-deoxyspergualin on steroid-resistant acute rejection in living related liver transplantation.
    Katoh H; Ohkohchi N; Orii T; Doi H; Satomi S
    Transplant Proc; 1997; 29(1-2):553-4. PubMed ID: 9123125
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine, FK-506 and other drugs in organ transplantation.
    Morris PJ
    Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of 15-deoxyspergualin on mononuclear cells from kidney recipients.
    Johansson-Borg A; Ohlman S; Groth CG
    Transplant Proc; 1992 Feb; 24(1):267-8. PubMed ID: 1539276
    [No Abstract]   [Full Text] [Related]  

  • 8. [15+/-deoxyspergualin, hope for patients with multiple sclerosis?].
    Kappos L; Theobald K; Hartung HP
    Nervenarzt; 1992 Dec; 63(12):768-71; discussion 772. PubMed ID: 1494394
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
    Murase N; Demetris AJ; Tanabe M; Miyazawa H; Valdivia LA; Nakamura K; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):425-6. PubMed ID: 7679817
    [No Abstract]   [Full Text] [Related]  

  • 10. Deoxyspergualin. Mechanism of action studies of a novel immunosuppressive drug.
    Tepper MA
    Ann N Y Acad Sci; 1993 Nov; 696():123-32. PubMed ID: 8109823
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined use of deoxyspergualin and FK 506 for temporary circulatory assist.
    Hachida M; Maeda T; Bonkohara Y; Nonoyama M; Niinami H; Koyanagi H
    Transplant Proc; 1999 Aug; 31(5):2049-55. PubMed ID: 10455968
    [No Abstract]   [Full Text] [Related]  

  • 12. Deoxyspergualin: mechanism of action and pharmacokinetics.
    Ramos EL; Nadler SG; Grasela DM; Kelley SL
    Transplant Proc; 1996 Apr; 28(2):873-5. PubMed ID: 8623442
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of concordant xenograft survival by treatment with FTY720.
    Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K
    Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental and clinical studies on the effectiveness of new immunosuppressive agents used in heart transplantation and transplantation-related complications].
    Nihon Kyobu Geka Gakkai Zasshi; 1995 May; 43(5):688-90. PubMed ID: 7561285
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of FK506 and 15-deoxyspergualin in rat orthotopic liver transplantation.
    Inagaki K; Fukuda Y; Sumimoto K; Matsuno K; Ito H; Takahashi M; Dohi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1069-71. PubMed ID: 2468210
    [No Abstract]   [Full Text] [Related]  

  • 16. The superior effect of the combination of FK 506 and deoxyspergualin on rat cardiac allograft survival.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transpl Int; 1994 Aug; 7(5):315-8. PubMed ID: 7527637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive mechanisms of deoxymethylspergualin and FK 506 on in vitro cytotoxic T lymphocytes.
    Nakata S; Shirakura R; Ito T; Fukuzawa M; Miyagawa S; Yamamoto S; Nozaki T; Matsumiya G; Izutani H; Matsuda H
    Transplant Proc; 1994 Aug; 26(4):1930-2. PubMed ID: 7520613
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
    Ueno M; Nakajima Y; Segawa M; Hisanaga M; Yabuuchi H; Yoshimura A; Nakano H
    Transplant Proc; 1992 Apr; 24(2):638-40. PubMed ID: 1373546
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive mechanisms of 15-deoxyspergualin on heterotopic heart transplantation in rats.
    Nakata S; Ito T; Shirakura R; Matsuda H; Fukuzawa M; Nakano S; Fukushima N; Kawashima Y
    Transplant Proc; 1991 Feb; 23(1 Pt 1):864-5. PubMed ID: 1825004
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin.
    Valdivia LA; Demetris AJ; Fung JJ; Celli S; Murase N; Starzl TE
    Transplantation; 1993 Mar; 55(3):659-61. PubMed ID: 7681230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.